Cerimon Pharmaceuticals
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Cerimon Pharmaceuticals sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Cerimon Pharmaceuticals: 7 sponsored US clinical trials, none currently recruiting.
Cerimon Pharmaceuticals sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 3 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Acute Pain, with 2 trials.
Upper-quartile sponsor footprint
Cerimon Pharmaceuticals sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED)
NCT00931866
Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion
NCT00869063
Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain
NCT00869180
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
NCT00646425
Diclofenac Patch for Treatment of Mild to Moderate Ankle Sprain
NCT00640705
Diclofenac Patch for Treatment of Mild to Moderate Tendonitis or Bursitis
NCT00640939
Basiliximab in Moderate to Severe Ulcerative Colitis
NCT00430898
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 3 | 3 |
Therapeutic Areas
How the Cerimon Pharmaceuticals archive is shaped
7 indexed studies, none listed as recruiting (0% open); 5 completed (71%).
Phase mix: 3 late (III/IV) vs 4 early (I/II) (balanced across stages).
Top condition: Acute Pain (2 trials), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Cerimon Pharmaceuticals: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Cerimon Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Cerimon Pharmaceuticals page
7 registered trials is a research-attention snapshot, not an endorsement of Cerimon Pharmaceuticals or any single study.
- None of Cerimon Pharmaceuticals's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Acute Pain is the condition Cerimon Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Acute Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cerimon Pharmaceuticals pipeline card: 7 registered trials from official public datasets.Report a data error.